Erivedge
$15,245.52
150mg Caja con 1 frasco con 28 cápsulas
... people are viewing this right now
Vismodegib is a drug for the treatment of basal-cell carcinoma. The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration approval.
Reviews
There are no reviews yet.